Continuous Glucose Monitoring-Based Composite Metrics: A Review and Assessment of Performance in Recent-Onset and Long-Duration Type 1 Diabetes

被引:7
作者
Donaldson, Laura E. [1 ,2 ]
Vogrin, Sara [1 ]
So, Michelle [3 ,4 ,5 ]
Ward, Glenn M. [1 ,2 ]
Krishnamurthy, Balasubramanian [1 ,2 ,3 ]
Sundararajan, Vijaya [1 ]
MacIsaac, Richard J. [1 ,2 ,6 ]
Kay, Thomas W. H. [1 ,3 ]
McAuley, Sybil A. [1 ,2 ,7 ]
机构
[1] Univ Melbourne, Dept Med, Melbourne, Australia
[2] St Vincents Hosp Melbourne, Dept Endocrinol & Diabet, Melbourne, Australia
[3] St Vincents Inst Med Res, Immunol & Diabet Unit, Melbourne, Australia
[4] Royal Melbourne Hosp, Dept Diabet & Endocrinol, Melbourne, Australia
[5] Northern Hosp, Dept Diabet & Endocrinol, Melbourne, Australia
[6] Univ Melbourne, Australian Ctr Accelerating Diabet Innovat, Melbourne, Australia
[7] Univ Melbourne, Dept Med, 29 Regent St, Fitzroy, VIC, Australia
关键词
Composite metric; Continuous glucose monitoring; Glucose time in range; Glycated hemoglobin; Hypoglycemia; Type; 1; diabetes; GLYCEMIC VARIABILITY PERCENTAGE; QUALITY; RISK; HYPOGLYCEMIA; MELLITUS; ADULTS; TIME;
D O I
10.1089/dia.2022.0563
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examined correlations between continuous glucose monitoring (CGM)-based composite metrics and standard glucose metrics within CGM data sets from individuals with recent-onset and long-duration type 1 diabetes. First, a literature review and critique of published CGM-based composite metrics was undertaken. Second, composite metric results were calculated for the two CGM data sets and correlations with six standard glucose metrics were examined. Fourteen composite metrics met selection criteria; these metrics focused on overall glycemia (n = 8), glycemic variability (n = 4), and hypoglycemia (n = 2), respectively. Results for the two diabetes cohorts were similar. All eight metrics focusing on overall glycemia strongly correlated with glucose time in range; none strongly correlated with time below range. The eight overall glycemia-focused and two hypoglycemia-focused composite metrics were all sensitive to automated insulin delivery therapeutic intervention. Until a composite metric can adequately capture both achieved target glycemia and hypoglycemia burden, the current two-dimensional CGM assessment approach may offer greatest clinical utility.
引用
收藏
页码:497 / 506
页数:10
相关论文
共 42 条
[1]   Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies [J].
Augstein, Petra ;
Heinke, Peter ;
Vogt, Lutz ;
Vogt, Roberto ;
Rackow, Christine ;
Kohnert, Klaus-Dieter ;
Salzsieder, Eckhard .
BMC ENDOCRINE DISORDERS, 2015, 15
[2]   Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range [J].
Battelino, Tadej ;
Danne, Thomas ;
Bergenstal, Richard M. ;
Amiel, Stephanie A. ;
Beck, Roy ;
Biester, Torben ;
Bosi, Emanuele ;
Buckingham, Bruce A. ;
Cefalu, William T. ;
Close, Kelly L. ;
Cobelli, Claudio ;
Dassau, Eyal ;
DeVries, J. Hans ;
Donaghue, Kim C. ;
Dovc, Klemen ;
Doyle, Francis J. ;
Garg, Satish ;
Grunberger, George ;
Heller, Simon ;
Heinemann, Lutz ;
Hirsch, Irl B. ;
Hovorka, Roman ;
Jia, Weiping ;
Kordonouri, Olga ;
Kovatchev, Boris ;
Kowalski, Aaron ;
Laffel, Lori ;
Levine, Brian ;
Mayorov, Alexander ;
Mathieu, Chantal ;
Murphy, Helen R. ;
Nimri, Revital ;
Norgaard, Kirsten ;
Parkin, Christopher G. ;
Renard, Eric ;
Rodbard, David ;
Saboo, Banshi ;
Schatz, Desmond ;
Stoner, Keaton ;
Urakami, Tatsuiko ;
Weinzimer, Stuart A. ;
Phillip, Moshe .
DIABETES CARE, 2019, 42 (08) :1593-1603
[3]   Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System [J].
Benhamou, Pierre-Yves ;
Adenis, Alice ;
Tourki, Yousra ;
Pou, Sylvie ;
Madrolle, Stephanie ;
Franc, Sylvia ;
Kariyawasam, Dulanjalee ;
Beltrand, Jacques ;
Klonoff, David C. ;
Charpentier, Guillaume .
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, :372-379
[4]   Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments [J].
Breitling, R ;
Armengaud, P ;
Amtmann, A ;
Herzyk, P .
FEBS LETTERS, 2004, 573 (1-3) :83-92
[5]   Temporal case-based reasoning for type 1 diabetes mellitus bolus insulin decision support [J].
Brown, Daniel ;
Aldea, Arantza ;
Harrison, Rachel ;
Martin, Clare ;
Bayley, Ian .
ARTIFICIAL INTELLIGENCE IN MEDICINE, 2018, 85 :28-42
[6]   Glycaemic variability in diabetes: clinical and therapeutic implications [J].
Ceriello, Antonio ;
Monnier, Louis ;
Owens, David .
LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (03) :221-230
[7]   Statistical Tools to Analyze Continuous Glucose Monitor Data [J].
Clarke, William ;
Kovatchev, Boris .
DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 :S45-S54
[8]   International Consensus on Use of Continuous Glucose Monitoring [J].
Danne, Thomas ;
Nimri, Revital ;
Battelino, Tadej ;
Bergenstal, Richard M. ;
Close, Kelly L. ;
DeVries, J. Hans ;
Garg, Satish ;
Heinemann, Lutz ;
Hirsch, Irl ;
Amiel, Stephanie A. ;
Beck, Roy ;
Bosi, Emanuele ;
Buckingham, Bruce ;
Cobelli, Claudio ;
Dassau, Eyal ;
Doyle, Francis J., III ;
Heller, Simon ;
Hovorka, Roman ;
Jia, Weiping ;
Jones, Tim ;
Kordonouri, Olga ;
Kovatchev, Boris ;
Kowalski, Aaron ;
Laffel, Lori ;
Maahs, David ;
Murphy, Helen R. ;
Norgaard, Kirsten ;
Parkin, Christopher G. ;
Renard, Eric ;
Saboo, Banshi ;
Scharf, Mauro ;
Tamborlane, William V. ;
Weinzimer, Stuart A. ;
Phillip, Moshe .
DIABETES CARE, 2017, 40 (12) :1631-1640
[9]   Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring [J].
El-Laboudi, Ahmed H. ;
Godsland, Ian F. ;
Johnston, Desmond G. ;
Oliver, Nick S. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (12) :806-812
[10]   Application of Glycemic Variability Percentage: Implications for Continuous Glucose Monitor Utilization and Analysis of Artificial Pancreas Data [J].
Garcia, Arturo ;
Balo, Andrew K. ;
Buckingham, Bruce A. ;
Hirsch, Irl B. ;
Peyser, Thomas A. .
DIABETES TECHNOLOGY & THERAPEUTICS, 2017, 19 (12) :699-706